NDC 0069-1311

RETACRIT

Epoetin Alfa-epbx

RETACRIT is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Epoetin.

• Product ID: 0069-1311_1b2796dd-509d-4a99-b464-48b8f3d2a217
• NDC: 0069-1311
• Product Type: Human Prescription Drug
• Proprietary Name: RETACRIT
• Generic Name: Epoetin Alfa-epbx
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2020-11-09
• Marketing Category: BLA / BLA
• Application Number: BLA125545
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: EPOETIN
• Active Ingredient Strength: 20000 [iU]/mL
• Pharm Classes: Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0069-1311-10

10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) > 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01)

• Marketing Start Date: 2020-11-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "RETACRIT" or generic name "Epoetin Alfa-epbx"

NDC	Brand Name	Generic Name
0069-1305	RETACRIT	epoetin alfa-epbx
0069-1306	RETACRIT	epoetin alfa-epbx
0069-1307	RETACRIT	epoetin alfa-epbx
0069-1308	RETACRIT	epoetin alfa-epbx
0069-1309	RETACRIT	epoetin alfa-epbx
0069-1311	RETACRIT	epoetin alfa-epbx
0069-1318	RETACRIT	epoetin alfa-epbx
59353-004	RETACRIT	RETACRIT
59353-002	RETACRIT	RETACRIT
59353-003	RETACRIT	RETACRIT
59353-010	RETACRIT	RETACRIT
59353-120	RETACRIT	RETACRIT
59353-220	RETACRIT	RETACRIT